Curis Inc (NASDAQ:CRIS)
| 0.7803 Delayed Data As of Feb 03 |  +0.0027 / +0.35%Today’s Change | 0.47 Today|||52-Week Range 3.76 | +41.87% Year-to-Date |
Latest CRIS News | Press Releases
No recent news for Curis Inc.
Today’s Trading
| Previous close | 0.78 |
| Today’s open | 0.78 |
| Day’s range | 0.77 - 0.79 |
| Volume | 7,408 |
| Average volume (3 months) | 784,148 |
| Market cap | $75.5M |
Data as of 3:58pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +19.25% |
| Earnings growth (this year) | -24.40% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -1.72% |
| P/E ratio | NM |
| Price/Sales | 40.93 |
| Price/Book | 0.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LPTXLeap Therapeutics In... | 0.00 | 0.00% |
| ---- | ||
| ---- | ||
| PRTGPortage Biotech Inc | -0.38 | -7.63% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $10.6M |
| Annual profit (last year) | -$45.4M |
| Net profit margin | -426.67% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
